Key facts
- It has raised $1.6M; the latest was Early Stage VC ($1.6M) in Jan 2025.
- Notable investors include Odyssee Venture, Business & Innovation Center, Innovosud, SATT AxLR.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Terratis
- ·The full record, as it builds
Funding rounds
No funding rounds for Terratis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Terratis
Operator of a prevention platform intended to reduce harmful insect populations using the sterile insect technique. The company offers sterilized male insects, regular releases, and a chemical-free method, enabling public health authorities and agricultural sectors to manage pest populations in an environmentally sustainable manner.
- Sector
- Business Products and Services (B2B)
- HQ
- Montpellier, France
- Founded
- 2024
- Employees
- 13
- Website
- terratis.fr/
- Ownership
- Privately Held (backing)
Terratis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Terratis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Terratis in its N-PORT filings yet. We sweep new filings monthly.